Patents by Inventor Gurpreet Bhatia

Gurpreet Bhatia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITORS OF C-JUN N-TERMINAL KINASES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS RELATING TO APOPTOSIS AND/OR INFLAMMATION
    Publication number: 20100035878
    Abstract: The present invention provides novel compounds of formula I and their use in the inhibition of c-Jun N-terminal kinases. The present invention further provides the use of these compounds in medicine, in particular in the prevention and/or treatment of neurodegenerative disorders related to apoptosis and/or inflammation.
    Type: Application
    Filed: October 6, 2009
    Publication date: February 11, 2010
    Applicant: EISAI R & D MANAGEMENT CO., LTD.
    Inventors: Afzal KHAN, Darren Peter MEDLAND, Gurpreet BHATIA
  • JNK INHIBITORS
    Publication number: 20090215771
    Abstract: The present invention provides novel compounds of formula I and their use in the inhibition of c-Jun N-terminal kinases. The present invention further provides the use of these compounds in medicine, in particular in the prevention and/or treatment of neurodegenerative disorders related to apoptosis and/or inflammation.
    Type: Application
    Filed: June 20, 2008
    Publication date: August 27, 2009
    Inventors: Piotr GRACZYK, Afzal KHAN, Gurpreet BHATIA, Yoichi IIMURA
  • JNK inhibitors
    Patent number: 7432375
    Abstract: The present invention provides novel compounds of formula (I) and their use in the inhibition of c-Jun N-terminal kinases. The present invention further provides the use of these compounds in medicine, in particular in the prevention and/or treatment of neurodegenerative disorders related to apoptosis and/or inflammation.
    Type: Grant
    Filed: March 5, 2004
    Date of Patent: October 7, 2008
    Assignee: Eisai R & D Management Co., Ltd.
    Inventors: Piotr Graczyk, Afzal Khan, Gurpreet Bhatia, Yoichi Iimura
  • Jun kinase inhibitors
    Patent number: 7314940
    Abstract: The present invention provides novel compounds of formula I and their use in the inhibition of c-Jun N-terminal kinases. The present invention further provides the use of these compounds in medicine, in particular in the prevention and/or treatment of neurodegenerative disorders related to apoptosis and/or inflammation.
    Type: Grant
    Filed: April 4, 2002
    Date of Patent: January 1, 2008
    Assignee: Eisai Co., Ltd.
    Inventors: Piotr Graczyk, Hirotoshi Numata, Afzal Khan, Vanessa Palmer, Darren Peter Medland, Hitoshi Oinuma, Gurpreet Bhatia
  • Azaindoles as inhibitors of c-Jun N-terminal kinases
    Patent number: 7291630
    Abstract: The present invention relates to novel 5-substituted 7-azaindole compounds of formula (I), their use in the inhibition of c-Jun N-terminal kinases, their use in medicine and particularly in the prevention and/or treatment of neurodegenerative disorders related to apoptosis and/or inflammation.
    Type: Grant
    Filed: March 17, 2003
    Date of Patent: November 6, 2007
    Assignee: Eisai Co., Ltd.
    Inventors: Piotr Graczyk, Hirotoshi Numata, Gurpreet Bhatia, Darren Peter Medland
  • Inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders relating to apoptosis and/or inflammation
    Publication number: 20070072896
    Abstract: The present invention provides novel compounds of formula I and their use in the inhibition of c-Jun N-terminal kinases. The present invention further provides the use of these compounds in medicine, in particular in the prevention and/or treatment of neurodegenerative disorders related to apoptosis and/or inflammation.
    Type: Application
    Filed: August 4, 2006
    Publication date: March 29, 2007
    Applicant: Eisai Co., Ltd.
    Inventors: Afzal Khan, Darren Medland, Gurpreet Bhatia
  • Jnk inhibitors
    Publication number: 20060270646
    Abstract: The present invention provides novel compounds of formula (I) and their use in the inhibition of c-Jun N-terminal kinases. The present invention further provides the use of these compounds in medicine, in particular in the prevention and/or treatment of neurodegenerative disorders related to apoptosis and/or inflammation.
    Type: Application
    Filed: March 5, 2004
    Publication date: November 30, 2006
    Applicant: Eisai Co., Ltd.
    Inventors: Piotr Graczyk, Afzat Khan, Gurpreet Bhatia, Yoichi Iimura
  • Synthesis
    Publication number: 20060235042
    Abstract: The present invention provides a novel substituted azaindoline intermediate of formula (I) and a method for its synthesis. The novel substitued azaindoline intermediate (I) is provided for use in the manufacture of 5-substituted 7-azaindolines and 5-substituted 7-azaindoles.
    Type: Application
    Filed: March 5, 2004
    Publication date: October 19, 2006
    Applicant: Eisai Co., Ltd.
    Inventors: Piotr Graczyk, Afzal Khan, Gurpreet Bhatia
  • Azaindoles as inhibitors of c-jun n-terminal kinases
    Publication number: 20060111390
    Abstract: The present invention relates to novel 5-substituted 7-azaindole compounds of formula (I), their use in the inhibition of c-Jun N-terminal kinases, their use in medicine and particularly in the prevention and/or treatment of neurodegenerative disorders related to apoptosis and/or inflammation. The invention also provides processes for manufacture of said compounds, compositions containing them and processes for manufacturing such compositions.
    Type: Application
    Filed: March 17, 2003
    Publication date: May 25, 2006
    Applicant: Eisai Co., Ltd.
    Inventors: Piotr Graczyk, Hirotoshi Numata, Gurpreet Bhatia, Darren Medland
  • Jun kinase inhibitors
    Publication number: 20040235864
    Abstract: The present invention provides novel compounds of formula I 1
    Type: Application
    Filed: April 23, 2004
    Publication date: November 25, 2004
    Inventors: Piotr Graczyk, Hiroshi Numata, Afzal Khan, Vanessa Palmer, Darren Peter Medland, Hitoshi Oinuma, Gurpreet Bhatia